{"id":530687,"date":"2021-02-17T17:02:01","date_gmt":"2021-02-17T17:02:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=530687"},"modified":"2021-02-17T17:02:01","modified_gmt":"2021-02-17T17:02:01","slug":"acute-heart-failure-competitive-analysis-report-2020-emerging-therapies-and-key-pharma-players-involved","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/acute-heart-failure-competitive-analysis-report-2020-emerging-therapies-and-key-pharma-players-involved_530687.html","title":{"rendered":"Acute Heart failure Competitive Analysis Report 2020: Emerging Therapies and Key Pharma Players Involved"},"content":{"rendered":"
\"Acute<\/a><\/p>\n
\n
DelveInsight Business Research LLP<\/div>\n<\/div>\n<\/div>\n
“Acute Heart failure (AHF) Pipeline Insight, 2020” report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Acute Heart failure (AHF) market. A detailed picture of the Acute Heart failure (AHF) pipeline landscape is provided, which includes the disease overview and Acute Heart failure (AHF) treatment guidelines.\n<\/div>\n

DelveInsight launched a new report on Acute Heart failure Pipeline Insight, 2020<\/strong><\/a>.<\/p>\n

Acute Heart failure (AHF) Pipeline Insight, 2020<\/strong><\/a> report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Acute Heart failure (AHF) market. A detailed picture of the Acute Heart failure (AHF) pipeline landscape is provided, which includes the disease overview and Acute Heart failure (AHF) treatment guidelines.<\/p>\n

\"\"<\/p>\n

Heart Failure (HF), also known as congestive HF, is bifurcated as left-side HF (when the heart is unable to pump enough oxygen in the blood to the body) and right-side HF (when the heart is unable to fill itself with enough blood).<\/div>\n
 <\/div>\n
Acute heart failure (AHF) is broadly defined as a rapid onset of new or worsening signs and symptoms of HF. It is often a potentially life-threatening condition requiring hospitalization, and emergency treatment aim to manage fluid overload and hemodynamic compromise. This umbrella term includes patients presenting for the first time with typical symptoms and signs of heart failure (de novo AHF) and those with worsening of their pre-existing cardiomyopathy (acute decompensated heart failure). <\/div>\n
 <\/div>\n
Request for a detailed sample copy of our report: https:\/\/www.delveinsight.com\/sample-request\/acute-heart-failure-ahf-pipeline-insight<\/span><\/a><\/strong><\/div>\n
 <\/div>\n
Key Pharma Players involved:<\/strong><\/div>\n
\n

1. Boehringer Ingelheim\/Eli Lilly and Company<\/p>\n

2. Windtree Therapeutics<\/p>\n

3. Arena Pharmaceuticals<\/p>\n<\/div>\n

Click here and get access to free sample pages of our report.<\/strong><\/a><\/p>\n

Table of Contents:<\/strong><\/p>\n

1. Report Introduction<\/span><\/p>\n

2. Acute Heart failure (AHF) <\/span><\/p>\n

4. Acute Heart failure (AHF) – DelveInsight’s Analytical Perspective<\/p>\n

5. Therapeutic Assessment<\/p>\n

6. Acute Heart failure (AHF) Late Stage Products (Phase-III)<\/p>\n

7. Acute Heart failure (AHF) Mid Stage Products (Phase-II)<\/span><\/p>\n

8. Early Stage Products (Phase-I)<\/span><\/p>\n

9. Pre-clinical Products and Discovery Stage Products<\/span><\/p>\n

10. Inactive Products<\/span><\/p>\n

11. Dormant Products<\/span><\/p>\n

12. Acute Heart failure (AHF) Discontinued Products<\/span><\/p>\n

13. Acute Heart failure (AHF) Product Profiles<\/span><\/p>\n

14. Acute Heart failure (AHF) Key Companies<\/p>\n

15. Acute Heart failure (AHF) Key Products<\/span><\/p>\n

16. Dormant and Discontinued Products<\/span><\/p>\n

17. Acute Heart failure (AHF) Unmet Needs<\/p>\n

18. Acute Heart failure (AHF) Future Perspectives<\/span><\/p>\n

19. Acute Heart failure (AHF) Analyst Review  <\/span><\/p>\n

20. Appendix<\/span><\/p>\n

21. Report Methodology<\/span><\/p>\n

Download our report: https:\/\/www.delveinsight.com\/report-store\/acute-heart-failure-ahf-pipeline-insight<\/a><\/strong><\/p>\n

About DelveInsight<\/span>
<\/strong>DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end to end comprehensive solutions to improve their performance.<\/p>\n

Media Contact<\/span>
Company Name:<\/strong> DelveInsight Business Research LLP<\/a>
Contact Person:<\/strong> Kritika Rehani
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> 9193216187
Address:<\/strong>304 S. Jones Blvd #2432
City:<\/strong> Las Vegas
State:<\/strong> Nevada
Country:<\/strong> United States
Website:<\/strong> https:\/\/www.delveinsight.com\/<\/a><\/p>\n

<\/object>\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

DelveInsight Business Research LLP “Acute Heart failure (AHF) Pipeline Insight, 2020” report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Acute Heart failure (AHF) market. A detailed picture of the Acute Heart failure … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,435,405,406,404],"tags":[],"class_list":["post-530687","post","type-post","status-publish","format-standard","hentry","category-Business","category-Europe","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/530687","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=530687"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/530687\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=530687"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=530687"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=530687"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}